Home » Topics » BioWorld Science

BioWorld Science
RSS

Q2 at NeoTherapeutics marked by milestone achievements

Aug. 31, 2001

Biovail seeks FDA approval of Cardizem XL

Aug. 31, 2001

Salix acquires rights to Colazal for Japan, Korea and Taiwan

Aug. 31, 2001

Drug abuse treatment subject of SBIR grant awarded to Albany Molecular Research

Aug. 31, 2001

Wyeth-Ayerst notifies health professionals of safety information for Neumega

Aug. 31, 2001

Tranzyme establishes collaboration with NeoGenesis

Aug. 31, 2001

Biopure's Hemopure reaches clinical milestone

Aug. 31, 2001

Demegen and Dow to design new compounds

Aug. 31, 2001

ImClone Systems reports update on major products

Aug. 31, 2001

Somatostatin analogue as a potential DMARD for patients with RA

Aug. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...